{"id":"https://openalex.org/W4241529024","doi":"https://doi.org/10.1093/ibd/izy037.003","title":"P135 BIOLOGICAL EVIDENCE OF TOFACITINIB EFFICACY IN CROHN\u2019S DISEASE","display_name":"P135 BIOLOGICAL EVIDENCE OF TOFACITINIB EFFICACY IN CROHN\u2019S DISEASE","publication_year":2018,"publication_date":"2018-01-18","ids":{"openalex":"https://openalex.org/W4241529024","doi":"https://doi.org/10.1093/ibd/izy037.003"},"language":"en","primary_location":{"id":"doi:10.1093/ibd/izy037.003","doi":"https://doi.org/10.1093/ibd/izy037.003","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izy037.003","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044505993","display_name":"Evangelos A. Theodorou","orcid":"https://orcid.org/0000-0002-0834-5738","observed_orcids":["https://orcid.org/0000-0002-0834-5738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evangelos Theodorou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Peirang Cao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peirang Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083772277","display_name":"Fotios Karagiannis","orcid":"https://orcid.org/0000-0002-1030-0635","observed_orcids":["https://orcid.org/0000-0002-1030-0635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fotios Karagiannis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086678766","display_name":"Eden Park","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eden Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060108766","display_name":"Adam S. Cheifetz","orcid":"https://orcid.org/0000-0002-6010-1896","observed_orcids":["https://orcid.org/0000-0002-6010-1896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Cheifetz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062491410","display_name":"Alan C. Moss","orcid":"https://orcid.org/0000-0003-0179-5477","observed_orcids":["https://orcid.org/0000-0003-0179-5477","https://orcid.org/0009-0007-0879-3884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan C Moss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113592935","display_name":"Efi G. Kokkotou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Efi Kokkotou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3862,"currency":"USD","value_usd":3862},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"suppl_1","first_page":"S48","last_page":"S49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":1.0},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.9893653392791748},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7727456092834473},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.6664115190505981},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6113604307174683},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4980151653289795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4724224805831909},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43425512313842773},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.43218088150024414},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.4206414222717285},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38911980390548706},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.34429121017456055},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3265356421470642},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21877595782279968},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1779709756374359},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ibd/izy037.003","doi":"https://doi.org/10.1093/ibd/izy037.003","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ibd/izy037.003","pdf_url":null,"source":{"id":"https://openalex.org/S45123234","display_name":"Inflammatory Bowel Diseases","issn_l":"1078-0998","issn":["1078-0998","1536-4844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Inflammatory Bowel Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3170416748","https://openalex.org/W4252619505","https://openalex.org/W2990987182","https://openalex.org/W7125231607","https://openalex.org/W4224260781","https://openalex.org/W2784225612","https://openalex.org/W2976021144","https://openalex.org/W2587875644","https://openalex.org/W3105798162","https://openalex.org/W2999162939"],"abstract_inverted_index":{"While":[0],"phase":[1],"II-III":[2],"trials":[3,34],"clearly":[4],"demonstrated":[5],"efficacy":[6],"of":[7,32,65,88,97,113,138,175,203,225,227,287],"tofacitinib,":[8],"an":[9],"oral":[10],"small":[11],"molecule":[12],"pan-JAK":[13],"inhibitor,":[14],"in":[15,19,61,71,180,212,217,220,244,267],"patients":[16,75,140,245,254],"with":[17,141,145,198,222,231,246,255],"UC,":[18],"CD":[20,142,181],"tofacitinib":[21,147,172,239,262],"did":[22],"not":[23],"differ":[24],"from":[25,81,134,200],"placebo,":[26],"raising":[27],"questions":[28],"about":[29,37],"the":[30,86,135,201,223],"design":[31],"those":[33],"but":[35,219],"also":[36,208],"tofacitinb":[38],"elicited":[39],"biological":[40,236],"mechanisms":[41,286],"that":[42,238],"can":[43,249],"be":[44,242,250],"beneficial":[45,243],"for":[46,154,161],"only":[47],"UC.":[48],"Subsequently,":[49],"second":[50],"generation":[51],"JAK-1":[52],"selective":[53,280],"inhibitors":[54,69,281],"such":[55],"as":[56],"filgotinib":[57],"were":[58,143,152,178,193],"found":[59],"efficacious":[60],"CD,":[62],"underscoring":[63],"lack":[64],"understanding":[66],"how":[67],"JAK":[68,279],"work":[70],"IBD":[72,229,256],"and":[73,117,127,159,183,191,263,282],"which":[74,108,210],"are":[76],"more":[77,195,257],"likely":[78,258],"to":[79,171,214,252,259,261,275],"benefit":[80],"their":[82,284],"use.":[83],"To":[84],"overcome":[85],"limitations":[87],"current":[89],"drug":[90],"evaluation":[91],"approaches":[92],"using":[93,121],"primarily":[94],"mouse":[95],"models":[96],"experimental":[98],"colitis,":[99],"we":[100],"have":[101],"developed":[102,278],"a":[103,272],"Therapeutic":[104],"Response":[105],"Predictor":[106],"Assay-TheRPA,":[107],"is":[109,211],"based":[110],"on":[111],"treatment":[112,226,240],"patient-derived":[114],"tissue":[115],"explants":[116,230],"has":[118],"been":[119],"validated":[120],"anti-TNF":[122],"(45%":[123],"patient":[124],"response":[125,169],"rate":[126],"87%":[128],"test":[129],"accuracy).":[130],"Punch":[131],"biopsies":[132],"obtained":[133],"inflamed":[136],"mucosa":[137],"12":[139],"cultured":[144],"100uM":[146],"or":[148],"vehicle.":[149],"Culture":[150],"supernatants":[151],"collected":[153],"multiplex":[155],"cytokine":[156],"analysis":[157],"(16-plex)":[158],"tissues":[160],"RNA":[162],"extraction":[163],"followed":[164],"by":[165],"RNAseq":[166],"analysis.":[167],"TheRPA-based":[168],"rates":[170],"(ie":[173],"inhibition":[174],">2":[176],"cytokines)":[177],"comparable":[179],"(8/12)":[182],"UC":[184],"(6/9)":[185],"patients.":[186],"TNFa,":[187],"GM-CSF,":[188],"MCP-1,":[189],"IL-8":[190],"IL-6":[192],"inhibited":[194],"frequently,":[196],"consistent":[197],"reports":[199],"field":[202],"rheumatoid":[204],"arthritis.":[205],"IL-10":[206],"was":[207],"downregulated,":[209],"contrast":[213],"previous":[215],"findings":[216],"mice,":[218],"agreement":[221],"effects":[224],"human":[228],"anti-TNF.":[232],"Our":[233],"study":[234],"provides":[235],"evidence":[237],"might":[241],"CD.":[247],"TheRPA":[248],"used":[251],"select":[253],"respond":[260],"guide":[264],"tailored":[265],"therapies":[266],"IBD.":[268],"Finally,":[269],"it":[270],"represents":[271],"suitable":[273],"platform":[274],"evaluate":[276],"newly":[277],"uncover":[283],"specific":[285],"actions.":[288]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}